Collagen stimulator vs filler: mechanism, onset, reversibility and overfill risk

The basics

Collagen stimulator vs filler: two different mechanisms

A hyaluronic acid (HA) filler is a cross-linked gel. It binds water and occupies space where it is placed, so the change is visible on the day, and the body breaks the gel down slowly over time. It is, in effect, the product doing the work.

A collagen stimulator, or biostimulator, leaves behind particles that the body clears slowly while laying down its own collagen around them. The three you will meet in Singapore are poly-L-lactic acid (PLLA), polycaprolactone (PCL) and calcium hydroxylapatite (CaHA). PCL and CaHA come in a gel carrier that gives some shape at first; PLLA is mixed with water that is absorbed within days. In each case, the longer-term effect depends on how your tissue responds.

Both groups are regulated the same way here: the Health Sciences Authority (HSA) classes all dermal fillers as Class D medical devices, its highest risk class, and they are injected by a doctor after assessment.

Side by side

HA filler vs PLLA vs PCL vs CaHA at a glance

These are general patterns drawn from the studies cited below and from how each material works. The doctor's technique, the area treated and your own tissues change every row, and results vary between people.

Longer-lasting is not automatically better. A material that lasts longer also leaves you living with any misjudgement for longer, which is why reversibility sits alongside duration in this table.

Onset

Onset: immediate shape vs gradual change

HA filler gives a result you can see before you leave, which is useful for precise structural changes and for people who want to judge one small step at a time. Swelling settles over days to a couple of weeks, and the doctor reviews the result then.

Collagen stimulators work on a delay. In a 2026 randomised trial of 252 people in China treated for nasolabial folds, HA did better at week 4, while a PLLA product did better from week 36 onwards; the PLLA group needed more early sessions. With PCL and CaHA, the gel carrier gives some early shape that is then absorbed as collagen forms, over roughly two to three months for the PCL gel.

The practical point is timing. A biostimulator result cannot be judged on the day, and adding more before the earlier treatment has matured is one of the ways faces end up overcorrected.

Duration

How long each lasts, and why the label is not the whole story

HA filler is often described as lasting six months to two years depending on the area and product, but the gel can outlast the look. In an MRI study of 33 people with mid-face filler, HA was still present in all of them at least two years after injection, and in one person up to 15 years later. That persistence is central to how overfilling builds up.

For PLLA, a randomised trial measured improvement up to 25 months after the last treatment. For PCL, a manufacturer-linked review gives at least 18 months for the S version and at least 24 months for M. For CaHA, results are commonly quoted at 12 to 18 months, and in a follow-up of 102 people, 40% of treated folds were still rated improved at least 30 months after the last injection.

These figures come from particular products, areas and study designs, often nasolabial folds. Your own result depends on your age, metabolism, the area and the amount used.

Reversibility

Reversibility: only hyaluronic acid can be dissolved

HA filler can be broken down with hyaluronidase, an enzyme injected into the gel. That allows lumps, migration or an overfilled look to be corrected, and it is the emergency treatment if HA blocks a blood vessel. A UK guideline sets out its safe use, including allergy precautions in people who react strongly to bee or wasp stings.

PLLA and PCL have no dissolving enzyme. For CaHA, sodium thiosulfate breaks the material down when in direct contact in the laboratory, but in a cadaver study it did not dissolve CaHA lodged inside facial arteries, and the authors concluded that CaHA still lacks a suitable antidote.

This matters for the rare but serious risk of a blocked vessel. In 2023 HSA reported Singapore's first case of blindness after a dermal filler, which involved a poly-D,L-lactic acid biostimulator; HSA found no product quality issue. Biostimulators carry this risk like any injected material, and with them there is no enzyme to fall back on.

Overfill

Overfill risk: how each can end up looking like too much

With HA, overfilling usually builds slowly. A 2026 review of facial overfilled syndrome describes it as more than simple excess volume: a mismatch with the anatomy, changes in how the face moves, and the cumulative load of repeated treatments. Because HA binds water and persists, top-ups layer onto earlier gel, and the face can look puffy, wide or heavy, especially when smiling.

With collagen stimulators, the early product is less likely to look heavy for long, because PLLA's water is absorbed and the PCL or CaHA gel is resorbed. The risk shifts instead to overcorrection from stacking sessions before earlier ones have matured, too much product in one area, or placing it where volume was never lost. What remains is your own collagen and fibrous tissue around particles, so it cannot be dissolved, and nodules can occur with any of them.

The same review describes ultrasound-guided hyaluronidase as the established approach for excess HA, and says that newer add-on methods, including energy-based devices and small-volume liposuction, call for strict caution. That is a fair standard for any correction plan.

Overfilled before

If you have been overfilled before

If a past result looked too much, the instinct to 'fix it' with a different product is understandable, but adding a non-dissolvable material to a face that already holds unknown filler is a step that can easily compound the problem. A safer order starts with finding out what is there.

Many people find that, once the excess has been reduced, they need far less than they expected, and some need nothing.

• Map first: ultrasound can show where filler sits, which layer, roughly how much, and whether it looks like HA or a particle-based product.
• Treat the cause: dissolve the HA that is driving the heaviness, selectively rather than everywhere, then wait at least two weeks, often longer, for the tissues to settle.
• Reassess before adding: decide whether anything is needed only once the face has settled, and if so start with the smallest, preferably reversible, step.
• Be wary of layering a long-lasting biostimulator over unknown filler; one small 2026 study used PCL after dissolving in overfilled faces, but it was preliminary and uncontrolled.
• For excess from non-HA products, options include time, injections into nodules, surgical removal of a discrete lump, and, in Dr Sin Yong's own clinical protocol described on drsinyong.com, the Sculpting mode of Time Freeze Laser LCLR® after ultrasound mapping, which is not tested in published trials and can remove more fat than intended.

Choosing

Which tends to suit which concern

The choice depends on what has changed in your face, how quickly you want to see it, and how much you value being able to undo it.

If hollowing has appeared quickly, you have lost weight without trying, or one side has changed more than the other, see a doctor about the cause first.

• A specific structural change, such as a short chin, flat cheekbone or hollow temple, or your first injectable: HA filler is often the starting point because it is precise and reversible.
• Broad, gradual volume loss or early loss of support, in someone who can wait and return: PLLA is often discussed.
• Support with some shape on the day and a longer collagen phase, accepting it cannot be dissolved: PCL or CaHA may be discussed.
• Skin quality rather than volume: a skin booster or bio-remodelling HA injection is usually more relevant than either filler or biostimulator.
• Heavy sagging with excess skin: lifting or a plastic surgeon's opinion; no injectable removes skin.

Safety

Who should not have them, and warning signs after treatment

Fillers and biostimulators are not advised during pregnancy or breastfeeding, with active infection or inflammation in the area, or with allergy to a component. Autoimmune disease, keloid scarring, blood thinners and earlier non-absorbable implants should be discussed first. Biostimulators are generally not used in the lips. A dermatologist is the right first stop for an active skin disease, and a plastic surgeon for persistent nodules that may need removal or for surgical lifting.

Bruising and swelling are common and settle over days. Seek help at once if, after any injection, skin near the area turns pale, white, blotchy or dusky, pain keeps increasing, or your vision changes. Contact the treating clinic immediately or go to an emergency department.

At SkinRev Lab

What happens at SkinRev Lab

HA fillers, PLLA and PCL collagen biostimulators and filler correction are performed by Dr Sin Yong after a consultation, at SkinRev Lab, #B1-28 CityLink Mall, 1 Raffles Link, linked underground to City Hall and Esplanade MRT, open daily 11am to 8pm (WhatsApp +65 8266 9585), or at IN Eternity Clinic, 9 Scotts Road, #12-01 Pacific Plaza, beside Orchard MRT, Monday to Saturday 11am to 8pm (WhatsApp SkinRev Lab on +65 8266 9585 or IN Eternity Clinic on +65 8815 3008).

His approach to anyone with earlier filler is to image and assess it before adding more, to treat the layer that has actually changed, and always to include no treatment as an option. He explains which material, if any, fits your face and why, along with the risks. Treatment is priced at consultation, and our pages do not commit to a brand, so ask which product would be used.

Sources

References & sources

1. Wang Z, Ting W, Zhao H, et al. Long-term correction of nasolabial folds using poly-L-lactic acid microspheres: a multicenter, double-blinded, randomized trial. Aesthet Surg J Open Forum. 2026;8:ojag001. PMID 41694326.
2. Master M, Azizeddin A, Master V. Hyaluronic acid filler longevity in the mid-face: a review of 33 magnetic resonance imaging studies. Plast Reconstr Surg Glob Open. 2024;12(7):e5934. PMID 39015357.
3. Christen MO, Vercesi F. Polycaprolactone: how a well-known and futuristic polymer has become an innovative collagen-stimulator in esthetics. Clin Cosmet Investig Dermatol. 2020;13:31-48. PMID 32161484.
4. Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J. 2010;30(2):235-238. PMID 20442101.
5. Yankova M, Pavicic T, Frank K, et al. Intraarterial degradation of calcium hydroxylapatite using sodium thiosulfate: an in vitro and cadaveric study. Aesthet Surg J. 2021;41(5):NP226-NP236. PMID 33544840.
6. Murray G, Convery C, Walker L, Davies E. Guideline for the safe use of hyaluronidase in aesthetic medicine, including modified high-dose protocol. J Clin Aesthet Dermatol. 2021;14(8):E69-E75. PMID 34840662.
7. Zhou C, Che Q, Zhao R, Wang H, Wa Q. Facial overfilled syndrome: a narrative clinical review. Clin Cosmet Investig Dermatol. 2026;19:600459. PMID 41948082.
8. Health Sciences Authority, Singapore. HSA concludes its investigation into AestheFill. 12 October 2023.

Common questions

Your questions,
answered